Herein, we report the successful continuation of VDZ as maintenance therapy without TB relapse induction in a patient with Crohn’s disease (CD) who developed anti-TNF-alpha agent-associated latent TB infection reactivation. This evidence concerns the gene TNF and Crohn disease.